Valuation check: IMRN's profit margin is -62.57%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
Immuron Limited (IMRN) currently reports a profit margin of -62.57% as of December 2025. That compares with -1.14% in the prior-year period — up 45.2% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Immuron Limited's profit margin history and peer comparisons.
Immuron Limited's profit margin increased from -1.14% to -62.57% — a 45.2% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Immuron Limited's profit margin of -62.57% is lower than the Healthcare sector average of 15.58%. That is roughly 501.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Immuron Limited's current -62.57% should be judged against Healthcare norms (sector average: 15.58%) and against IMRN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -62.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Immuron Limited, and consider following IMRN for alerts when major investors trade the stock.